Found: 73
Select item for more details and to access through your institution.
Who Should Go First in Trials with Scarce Agents?: The Views of Potential Participants.
- Published in:
- IRB: Ethics & Human Research, 2007, v. 29, n. 4, p. 1
- By:
- Publication type:
- Article
Reducing Tobacco-Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop.
- Published in:
- Oncologist, 2014, v. 19, n. 1, p. 23, doi. 10.1634/theoncologist.2013-0230
- By:
- Publication type:
- Article
Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC.
- Published in:
- Oncologist, 2008, v. 13, n. 11, p. 1166, doi. 10.1634/theoncologist.2008-0108
- By:
- Publication type:
- Article
Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 415, p. 1, doi. 10.1126/scitranslmed.aao4307
- By:
- Publication type:
- Article
Comparing Detection Schemes for Adversarial Images against Deep Learning Models for Cancer Imaging.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1548, doi. 10.3390/cancers15051548
- By:
- Publication type:
- Article
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2985, doi. 10.3390/cancers12102985
- By:
- Publication type:
- Article
Future Directions in the Management of Non--Small Cell Lung Cancer Harboring Driver Mutations.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 9, p. 562
- By:
- Publication type:
- Article
Monitoring With ctDNA for Immunotherapy Response in Lung Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 12, p. 843
- By:
- Publication type:
- Article
Tracing Steps of Clinical Research in Lung Cancer.
- Published in:
- Oncology (08909091), 2021, v. 35, n. 5, p. 242
- By:
- Publication type:
- Article
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.
- Published in:
- Nature, 2014, v. 515, n. 7528, p. 563, doi. 10.1038/nature14011
- By:
- Publication type:
- Article
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. e843, doi. 10.1093/oncolo/oyae062
- By:
- Publication type:
- Article
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF).
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1407, doi. 10.1634/theoncologist.2018-0044
- By:
- Publication type:
- Article
Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The fork in the road: Waun Ki Hong, John Mendelsohn, and the reinvigoration of The University of Texas MD Anderson Cancer Center.
- Published in:
- 2019
- By:
- Publication type:
- biography
Should chemotherapy plus immune checkpoint inhibition be the standard front-line therapy for patients with metastatic non-small cell lung cancer?
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Phase 2 Study of Cetuximab in Combination With Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Nonsmall Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 8, p. 1713, doi. 10.1002/cncr.24148
- By:
- Publication type:
- Article
The Changing Face of Phase 1 Cancer Clinical Trials: New Challenges in Study Requirements.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 8, p. 1592, doi. 10.1002/cncr.24171
- By:
- Publication type:
- Article
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 60, doi. 10.1016/j.cllc.2021.10.002
- By:
- Publication type:
- Article
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 187, doi. 10.1016/j.cllc.2021.01.001
- By:
- Publication type:
- Article
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 178, doi. 10.1016/j.cllc.2020.10.015
- By:
- Publication type:
- Article
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 170, doi. 10.1016/j.cllc.2020.09.013
- By:
- Publication type:
- Article
ADAURA: Phase III, Double-blind, Randomized Study of Osimertinib Versus Placebo in EGFR Mutation-positive Early-stage NSCLC After Complete Surgical Resection.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Emerging Science and Therapies in Non-small-Cell Lung Cancer: Targeting the MET Pathway.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 475, doi. 10.1016/j.cllc.2014.08.001
- By:
- Publication type:
- Article
Vandetanib and Indwelling Pleural Catheter for Non-Small-Cell Lung Cancer With Recurrent Malignant Pleural Effusion.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 5, p. 379, doi. 10.1016/j.cllc.2014.04.002
- By:
- Publication type:
- Article
Comparison of Patient Outcomes According to Histology Among Pemetrexed-Treated Patients With Stage IIIB/IV Non–Small-Cell Lung Cancer in Two Phase II Trials.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 2, p. 126, doi. 10.3816/CLC.2010.n.017
- By:
- Publication type:
- Article
Evolving Treatment Algorithms for Advanced Non–Small-Cell Lung Cancer: 2009 Looking Toward 2012.
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 6, p. 392, doi. 10.3816/CLC.2009.n.074
- By:
- Publication type:
- Article
Abstracts From: The 10th International Lung Cancer Congress June 17-20, 2009; Kohala Coast, HI.
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 5, p. E5, doi. 10.1016/S1525-7304(11)70447-8
- By:
- Publication type:
- Article
Evolving Treatment Algorithms for Advanced Non-small-cell Lung Cancer: 2009 Looking Toward 2012.
- Published in:
- Chinese Journal of Lung Cancer, 2010, v. 13, n. 3, p. 238, doi. 10.3779/j.issn.1009-3419.2010.03.16
- By:
- Publication type:
- Article
Future Directions - of Monoclonal Antibody Use in Personalized Lung Cancer Therapy.
- Published in:
- Oncology (08909091), 2010, v. 24, n. 13, p. 1226
- By:
- Publication type:
- Article
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 12, p. 859, doi. 10.1093/jnci/djq179
- By:
- Publication type:
- Article
Overview of the Efficacy of Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in Patients Who Previously Failed Platinum-based Therapies.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 12, p. 2710, doi. 10.1002/cncr.23442
- By:
- Publication type:
- Article
Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 11, p. 2449
- By:
- Publication type:
- Article
Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 8, p. 1733
- By:
- Publication type:
- Article
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 2, p. 340, doi. 10.1002/cncr.10629
- By:
- Publication type:
- Article
Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Gefitinib--a novel targeted approach to treating cancer.
- Published in:
- 2004
- By:
- Publication type:
- review
Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2017, v. 196, n. 11, p. 1443, doi. 10.1164/rccm.201610-2157OC
- By:
- Publication type:
- Article
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I participants’ views of quality of life and trial participation burdens.
- Published in:
- Supportive Care in Cancer, 2007, v. 15, n. 7, p. 885
- By:
- Publication type:
- Article
Immunotherapy Will Alter the NSCLC Treatment Landscape.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 5, p. 293
- By:
- Publication type:
- Article
Case: Former Smoker with Well- Differentiated Adenocarcinoma of the Lung.
- Published in:
- Personalized Medicine in Oncology, 2015, v. 4, n. 3, p. 167
- By:
- Publication type:
- Article
Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1328512
- By:
- Publication type:
- Article
Reversal of in vivo drug resistance by the transforming growth factor-β inhibitor decorin.
- Published in:
- International Journal of Cancer, 1997, v. 71, n. 1, p. 49, doi. 10.1002/(SICI)1097-0215(19970328)71:1<49::AID-IJC10>3.0.CO;2-4
- By:
- Publication type:
- Article
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer: A Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 16, p. 2149, doi. 10.1001/jama.290.16.2149
- By:
- Publication type:
- Article
Bayesian adaptive design for targeted therapy development in lung cancer -- a step toward personalized medicine.
- Published in:
- Clinical Trials, 2008, v. 5, n. 3, p. 181, doi. 10.1177/1740774508091815
- By:
- Publication type:
- Article
A Novel Small-Molecule Inhibitor Targeting CREB-CBP Complex Possesses Anti-Cancer Effects along with Cell Cycle Regulation, Autophagy Suppression and Endoplasmic Reticulum Stress.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0122628
- By:
- Publication type:
- Article
Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2010, v. 5, n. 11, p. 1, doi. 10.1371/journal.pone.0014124
- By:
- Publication type:
- Article